This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbruck-Centrum Fur Molekulare Medizin. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Sabine Engemann: Innovator in Neurodegenerative Disease Treatment
Introduction
Sabine Engemann is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment and diagnosis of neurodegenerative diseases. Her innovative work has the potential to impact many lives affected by these conditions.
Latest Patents
Engemann holds a patent for "Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases." This invention relates to pharmaceutical and diagnostic compositions, as well as the use of the active substances contained therein for preparing a pharmaceutical or diagnostic composition aimed at treating or diagnosing neurodegenerative disorders or amyloid diseases. She has 1 patent to her name.
Career Highlights
Sabine Engemann is associated with the Max Delbrück Center for Molecular Medicine, where she conducts her research and development. Her work at this esteemed institution has allowed her to explore innovative solutions to complex medical challenges.
Collaborations
Engemann collaborates with notable colleagues, including Phoebe Markovic and Erich Wanker. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.
Conclusion
Sabine Engemann's contributions to the treatment and diagnosis of neurodegenerative diseases highlight her role as an influential inventor. Her work continues to pave the way for future innovations in medicine.